In the pandemic’s aftermath, industries worldwide have shifted their investment priorities to deliver personalized Customer Experience (CX), and the life sciences commercial function is no exception. To stay resilient and keep pace with the evolving landscape, the life sciences industry has started to embrace technology to bring differentiation to its end users.
However, outdated tools and data fragmentation across business functions are hampering enterprises’ ability to deliver personalized experiences. Currently, commercial technology in the life sciences industry comprises fundamental technology such as CRM, content management systems, and marketing tools. These tools serve as repositories of information and offer limited insights into customers.
Hence, enterprises are augmenting these solutions by partnering with niche domain-specific providers and embracing advanced technologies such as data analytics and AI/ML. Such engagements are helping them develop customer-centric solutions that assist in targeted sales and messaging, boosting business performance and gaining a competitive edge. These solutions also assist internal stakeholders (such as IT departments, sales and marketing team, medical affairs, and sales representatives) in understanding customer behaviour and informing their commercial strategies.
In this report, we analyze the current state of the life sciences commercial technology market, deep dive into technology adoption, provide a detailed analysis of recent commercial market trends, explore the supply ecosystem, and discuss the implications for platform providers.
Scope
Industry: life sciences
Geography: global
Contents
In this report, we examine:
- Current state of commercial technology in the life sciences industry
- Emerging themes in commercial technology
- Supplier landscape and implications for platform providers
Membership (s)
Life Sciences Information Technology
Sourcing and Vendor Management
